Sign in

Dr. Kathryn J. Jackson

Director at EQTEQT
Board

About Dr. Kathryn J. Jackson

Independent EQT director since July 2019, age 67, with deep energy technology and utility experience. She serves on EQT’s Audit Committee and the Public Policy & Corporate Responsibility (PPCR) Committee, is deemed independent under NYSE standards, and attended at least 75% of Board/committee meetings with full attendance at the 2024 annual meeting . Her external public boards include Cameco Corporation (since 2017) and Portland General Electric Company (since 2014) .

Past Roles

OrganizationRoleTenureCommittees/Impact
KeySource, Inc.Director of Energy & Technology Consulting2015–2021
RTI International Metals (acquired by Alcoa)SVP & Chief Technology Officer2014–2015
Westinghouse Electric Company, LLCCTO & SVP, Research & Technology2009–2014
Rice Energy Inc.DirectorApr 2017–Nov 2017

External Roles

CompanyRoleTenureNotes
Cameco Corporation (NYSE: CCJ)Director2017–present Global uranium fuel provider
Portland General Electric Company (NYSE: POR)Director2014–present Fully integrated energy company

Board Governance

  • Committee assignments: Audit (member) and Public Policy & Corporate Responsibility (member) .
  • Committee activity: Audit met 7× in 2024; PPCR met 5× . The Audit Committee report lists Dr. Jackson among committee members .
  • Independence: Board determined Dr. Jackson is independent under EQT Corporate Governance Guidelines and NYSE listing standards .
  • Attendance: Each director attended ≥75% of combined Board/committee meetings; all directors attended the 2024 annual meeting .
  • Time-commitment policy: Non-employee directors limited to ≤4 public company boards (including EQT); Dr. Jackson’s three board seats are within EQT policy .

Fixed Compensation

Component (2024)AmountNotes
Board member annual cash retainer$85,000 Paid quarterly
Audit Committee member retainer$10,000 Excludes chair premiums
PPCR Committee member retainer$5,000 Excludes chair premiums
Actual fees earned (2024)$101,448 Reflects scheduled retainers and timing/proration
All other compensation (2024)$5,044 $5,000 EQT Foundation matching gifts + $44 insurance premium

Performance Compensation

Equity GrantGrant DateUnitsGrant-Date Fair ValueVestingUnvested RSUs at 12/31/24Deferred Stock Units
Annual RSU (director)Apr 17, 20245,830 $211,046 Vests at 2025 annual meeting; forfeitable if director voluntarily leaves prior 5,901 25,112 (EQT DDCP)

Director RSUs are time-based; no performance metrics or options apply to non-employee director equity grants .

Other Directorships & Interlocks

EntityRelationship to EQTTransaction/Interlock Disclosure
Cameco (CCJ); Portland General Electric (POR)Unrelated external boardsNo related person transactions involving Dr. Jackson disclosed for 2024; transactions disclosed pertain to RIG portfolio companies and Quantum-affiliated entities (not involving Jackson) .

Expertise & Qualifications

  • Regulatory/public policy, innovation, technology, and engineering expertise; experience with generation facilities and large energy trading/utility operations .
  • Extensive public company board experience (Cameco; Portland General Electric) .

Equity Ownership

ItemAmountNotes
Beneficial ownership (EQT common)36,891 shares Includes DSUs settled in stock per footnotes
Percent of class<1%* *Less than 1%
Deferred stock units (EQT DDCP)25,112 units Settled in common stock at distribution
Unvested RSUs5,901 units Includes accrued dividends
Exercisable options0 Directors do not receive options under current policy
Ownership guidelines5× annual cash retainer; 5-year compliance window Company states all non-employee directors have satisfied or are on track
Hedging/pledgingProhibited for directors Corporate Stock Trading Policy bars hedging/pledging

Governance Assessment

  • Strengths: Independent director with robust energy technology/regulatory credentials; active committee service (Audit, PPCR); strong attendance; equity alignment via annual RSUs and ownership guidelines; prohibition on hedging/pledging supports alignment .
  • Compensation structure: Cash retainers consistent with EQT policy; equity grants are time-based (not performance-driven), which is standard for directors and aligns long-term interests without incentivizing short-term risk-taking .
  • Conflicts/related party risk: No related person transactions disclosed involving Dr. Jackson; broader related-party controls (RIG governance policy) are documented, though not specific to her .
  • Time commitment: Holds three public company directorships (EQT, CCJ, POR), within EQT’s limit of four; ongoing monitoring appropriate but policy-compliant .
  • Investor confidence context: EQT reported 98% say-on-pay support in 2024 and emphasizes governance practices (independent chair, majority voting, proxy access), which bolsters overall governance quality during her tenure .